L-Carnitine L-Tartrate Storage — LCLT Tank Selection
L-Carnitine L-Tartrate Storage — Quaternary Amine Salt Tank Selection for Dietary Supplement, Pharmaceutical, and Infant Formula Manufacturing
L-Carnitine L-Tartrate (LCLT, C7H15NO3·C4H6O6, CAS 36687-82-8) is the stable crystalline salt form of L-carnitine, a quaternary-ammonium betaine essential for fatty-acid transport into mitochondria for beta-oxidation energy metabolism. The free-base L-carnitine (CAS 541-15-1) is intensely hygroscopic to the point of deliquescence at moderate humidity and is not commercially supplied as a free-flowing solid for routine handling; the L-tartrate salt is the dominant industrial form representing approximately 68% L-carnitine + 32% L-tartaric acid by mass. LCLT is supplied as a free-flowing white-to-pale-cream crystalline powder with mild characteristic odor, melting at 175-181°C with decomposition. Pharmaceutical USP-grade L-carnitine (the FDA-approved Carnitor product is the levocarnitine free-base form, manufactured by Sigma-Tau / Leadiant Biosciences) is approved for primary and secondary carnitine deficiency in dialysis patients and certain pediatric metabolic disorders. Dietary-supplement-grade LCLT is the dominant tonnage application as a sports-nutrition / energy / weight-management supplement active ingredient. Infant-formula-grade L-carnitine (free base or LCLT) is added to infant formulas at ~10 mg/L per FDA infant-formula-additive standards. This pillar covers tank-system selection, regulatory compliance, and field-handling reality for L-carnitine L-tartrate handling at the supplement, pharmaceutical, and infant-formula manufacturer scale.
The six sections below cite Lonza (Visp Switzerland + Nansha China — the dominant Western supplier under the Carnipure brand), Northeast Pharmaceutical Group (Shenyang China), Hengtai Pharmaceutical (China), Yiwu Hongyu, and Sigma-Tau / Leadiant Biosciences (US-Italy pharma supplier of Carnitor levocarnitine drug product) spec sheets. Regulatory citations point to USP-NF Levocarnitine monograph (the free-base pharma form) plus USP Levocarnitine Tartrate monograph, European Pharmacopoeia (Ph. Eur.) 11.0 monographs, FDA 21 CFR 211 cGMP, FDA 21 CFR 107 Infant Formula, ICH Q7 API GMP, ICH Q3D R2 Elemental Impurities, ICH M7 R2 Mutagenic Impurities, and FDA 21 CFR 111 Dietary Supplement cGMP.
1. Material Compatibility Matrix
L-Carnitine L-Tartrate in solid dry form is non-reactive with virtually all storage and handling materials at ambient conditions. The tartrate counter-ion confers significant moisture stability versus the deliquescent free base — LCLT is mildly hygroscopic above 70% relative humidity but does not deliquesce at ambient conditions. Aqueous LCLT solution at typical 1-10% (10-100 g/L) supplement formulation strength is mildly acidic (pH 3.0-4.5 from tartrate counter-ion; the free base is mildly basic) and non-corrosive to standard pharmaceutical-grade contact materials.
| Material | Dry powder LCLT | Aqueous (1-10%) | Free-base L-carnitine (deliquescent) | Notes |
|---|---|---|---|---|
| 316L stainless steel | A | A | A | Pharmaceutical standard for jacketed mixing/dissolution; electropolished interior |
| 304 stainless steel | A | A | A | Acceptable for product-contact at non-pharma scale |
| HDPE / XLPE | A | A | A | Standard for bulk dry storage + non-sterile aqueous holding |
| Polypropylene | A | A | A | USP Class VI grades for product-contact at non-sterile scale |
| PTFE / PFA | A | A | A | Premium for high-purity injectable-grade fittings + diaphragms |
| PVDF (Kynar) | A | A | A | Pharmaceutical-grade piping at WFI / purified-water service interface |
| Glass-lined steel | A | A | A | Standard for fine-chemical / API recrystallization vessels |
| FRP vinyl ester | B | B | B | Acceptable for bulk supplement-grade; not for pharma or infant-formula contact |
| Carbon steel | B | C | C | Iron contamination risk; tartrate may slowly chelate iron from steel surfaces |
| Aluminum | B | C | C | Slow corrosion at acidic tartrate pH; avoid for aqueous service |
| EPDM (USP Class VI) | A | A | A | Standard gasket for pharma jacketed-tank flange seals |
| Silicone (platinum-cured) | A | A | A | USP Class VI single-use bag films + transfer tubing |
| Buna-N (Nitrile) | A | A | A | Acceptable for non-pharma supplement food grade |
For pharmaceutical USP-grade L-carnitine handling, the dominant tank-system specification is 316L electropolished stainless dissolution + holding vessels with USP Class VI elastomer gaskets, climate-controlled (below 65% RH) bulk-powder warehouse storage, and validated CIP/SIP cycles. For dietary-supplement and infant-formula-additive handling at the larger tonnage scale, HDPE silos and HDPE day-tanks are standard.
2. Real-World Industrial Use Cases
Dietary Supplement Manufacturing (Dominant Use by Tonnage). L-Carnitine L-Tartrate is one of the largest-tonnage dietary-supplement active ingredients globally, sold as sports-nutrition products (energy, fat-burner, pre-workout formulations) and weight-management supplements. Typical capsule and tablet products contain 500-2,000 mg LCLT per dose (representing ~340-1,360 mg L-carnitine free-base equivalent). The dietary-supplement manufacturing scale uses 25-kg drum receipts at the encapsulation/tableting line. Per-batch use is typically 100-2,000 kg. Sports-nutrition liquid-shot products use LCLT at 1-3 g per 50-mL serving in flavored aqueous solutions. Compliance is governed by FDA 21 CFR 111 Dietary Supplement cGMP. Lonza's Carnipure-branded LCLT is the dominant premium specification globally with strict identity, assay, and impurity-profile certification.
Pharmaceutical Levocarnitine Drug Product (Carnitor). The FDA-approved levocarnitine drug product (Carnitor by Sigma-Tau / Leadiant Biosciences) is supplied as oral tablets, oral solution, and IV solution for primary and secondary L-carnitine deficiency in patients with chronic renal failure on dialysis (the dominant indication) and in pediatric metabolic disorders. The drug-product input is the L-carnitine free-base form (USP Levocarnitine monograph) rather than LCLT for the FDA-approved indication. Manufacturing scale at the Carnitor plant is modest relative to dietary-supplement scale.
Infant Formula Manufacturing. L-Carnitine (free-base or as the L-tartrate salt) is added to infant formulas at approximately 10 mg per liter per FDA 21 CFR 107.10 infant-formula-additive standards. Bovine-milk-based infant formulas naturally contain L-carnitine but soy-based, hypoallergenic-elemental, and many specialty pediatric medical-food formulations require supplemental L-carnitine to meet the regulatory minimum. Infant-formula manufacturers (Abbott Nutrition / Similac, Mead Johnson Nutrition / Enfamil, Nestle / Gerber, Reckitt / Mead Johnson) use pharma-grade or infant-formula-additive-grade input with strict elemental-impurity, microbial, and pesticide-residue specifications. Per-batch use at infant-formula plants is 5-50 kg per liquid-formula batch.
Animal Feed and Aquaculture. L-Carnitine and LCLT are added to feed and aquaculture diets at 50-200 ppm levels for fat-metabolism support in piglets, layer hens, and aquaculture finfish. Per-feed-mill use is modest (1-20 tonnes annually) but the segment is growing.
Cosmetic and Personal Care. L-Carnitine is added to topical cosmetic products (cellulite reduction creams, body-firming lotions) at 1-5% levels by various marketing claims. The cosmetic-grade specification is less stringent than pharmaceutical or infant-formula grade; per-batch use is 10-200 kg.
Veterinary Pharmaceuticals. Veterinary cardiac-support and feline-hepatic-lipidosis supplements use L-carnitine as an active ingredient at gram-per-day dosing. Per-batch use at veterinary-formulator scale runs 50-500 kg.
3. Regulatory Hazard Communication
OSHA and GHS Classification. L-Carnitine L-Tartrate is not classified as hazardous under GHS for acute health endpoints. There is no acute oral, dermal, or inhalation toxicity at relevant occupational exposures (LD50 oral rat >5,000 mg/kg; effectively non-toxic). The principal occupational hazard is dust generation at fine-powder bag-tip operations: LCLT fine powder may form combustible dust under unfavorable conditions per OSHA Combustible Dust National Emphasis Program guidance. Published Kst values for LCLT are limited but the chemistry's organic-quaternary-ammonium structure is consistent with St 1 dust class behavior.
NFPA 704 Diamond. LCLT rates NFPA Health 1, Flammability 1, Instability 0, no special hazard.
USP-NF Pharmacopeial Compliance. Pharmaceutical-grade L-Carnitine (free base) must meet USP-NF Levocarnitine monograph: Identification by IR spectroscopy match plus chemical confirmation; Assay 97.0-103.0% on dried basis; Specific Optical Rotation -29.5° to -32.5° (in water, c=10%); Loss on Drying NMT 4.0% (the deliquescent free-base form); Residue on Ignition NMT 0.1%; Heavy Metals replaced by ICH Q3D Elemental Impurities testing. Pharmaceutical-grade L-Carnitine L-Tartrate must meet USP Levocarnitine Tartrate monograph: similar identity and assay framework with the tartrate counter-ion verification step (Specific Optical Rotation +9.5° to +11.5° reflecting the combined L-carnitine and L-tartaric acid optical contributions). EP and JP monographs are functionally equivalent.
ICH Q3D R2 and ICH M7 Impurity Control. Same framework as other small-molecule APIs. The chemistry's two production routes are: (1) chemical synthesis from racemic intermediates with chiral resolution (the historical Lonza route), and (2) bacterial whole-cell biotransformation from gamma-butyrobetaine (the modern Lonza Carnipure fermentation route). The two routes have different impurity profiles: synthesis route requires control of solvent residuals + chiral-resolution byproducts; biotransformation route requires control of host-cell protein + DNA + endotoxin. Both routes meet pharmaceutical-grade specifications with appropriate process controls.
FDA 21 CFR 211 cGMP, 21 CFR 107 Infant Formula, and 21 CFR 111 Dietary Supplement cGMP. Pharmaceutical-grade L-carnitine API for FDA-approved drug-product manufacturing (Carnitor) is produced under 21 CFR 211 cGMP. Infant-formula-additive-grade L-carnitine is produced under FDA 21 CFR 106 / 107 infant-formula-quality standards, including specific microbial limits (Cronobacter sakazakii, Salmonella, Listeria absence) and pesticide-residue limits stricter than dietary-supplement grade. Dietary-supplement-grade LCLT is produced under 21 CFR 111. All three regulatory frameworks require identity testing, microbial limits, and elemental-impurity controls; the specific limits differ. Audited supplier qualification is the standard for all three segments.
DOT and Shipping. Not regulated as hazardous material under DOT, IATA, or IMDG. Standard non-hazardous powder shipping in fiber drums, bulk supersacks, or sea-container bulk applies.
4. Storage System Specification
Pharmaceutical Bulk Powder Storage. L-Carnitine L-Tartrate USP arrives in fiber drums (25 kg) or HDPE-lined supersacks (500 kg). Storage requires temperature 15-25°C, relative humidity below 65% (LCLT is mildly hygroscopic above 70% RH but stable in normal warehouse conditions; the deliquescent free-base form requires below 30% RH special handling and is not typical commercial bulk material). Dedicated pharmaceutical-grade or infant-formula-additive-grade segregated storage with full lot-level chain-of-custody. Shelf life is typically 24-36 months in unopened original packaging.
Free-Base L-Carnitine Special Handling. If pharmaceutical-grade free-base L-carnitine (USP Levocarnitine) is required for FDA-approved drug-product manufacturing, the deliquescent property mandates dry-room handling at below 30% RH. The material is typically supplied in nitrogen-blanketed sealed glass ampoules or vacuum-sealed pouches at small batch quantities; bulk-handling at supplement-scale tonnages is impractical, which is why LCLT is the dominant industrial form despite higher per-mass cost.
Dissolution / Holding Tank. A 200-2,000 gallon 316L electropolished stainless jacketed mixing tank is the standard for batch dissolution of pharmaceutical-grade or infant-formula-grade LCLT. Aqueous solubility is approximately 250 g/L at 25°C (much higher than tryptophan), allowing concentrated dissolution at the formulation step. Tank fittings include sanitary tri-clamp connections, sterile-filter vent for non-sterile holding or sterile breather for closed-system aseptic holding, and jacket for SIP at 80-95°C between batches. Mixing time at 5-10% concentration is typically 15-30 minutes at 60-100 rpm.
Dietary Supplement Manufacturing Tank. Dietary-supplement encapsulation and tableting operations typically use the dry-powder LCLT in granulation/blending steps rather than aqueous dissolution. Standard 316L stainless V-blender or ribbon-blender handles the dry-blending step. For sports-nutrition liquid-shot and ready-to-drink product manufacturers, 200-1,500 gallon HDPE rotomolded or 316L stainless mixing tanks dissolve LCLT at 1-3% into flavored beverage formulations.
Infant Formula Manufacturing Tank. Infant-formula plant operations use 316L stainless jacketed mixing tanks at the formulation step with strict CIP/SIP validation between batches. The LCLT input dissolves into the formula matrix at ~10 mg/L addition rate with mild mixing.
Secondary Containment. Same framework as other amino-acid-related APIs.
5. Field Handling Reality
Hygroscopic Behavior — Tartrate vs. Free Base. LCLT is mildly hygroscopic above 70% RH and will surface-cake in fiber drums after 60-180 days of high-humidity warehouse exposure. Reconstitution by mechanical breakup or heated-air drying restores free-flowing powder. The deliquescent free-base L-carnitine is fundamentally different: at 50% RH the free base will absorb enough water to liquefy a fiber-drum lot within hours-to-days. This is the primary commercial reason that LCLT (or alternative salt forms like L-carnitine fumarate) is the industrial standard despite the lower per-mass L-carnitine content (~68% in the tartrate vs. 100% in free base). Climate-controlled warehouse storage (below 65% RH year-round) prevents hygroscopic caking issues with LCLT entirely.
Bitter Taste in Aqueous Solution. L-Carnitine in aqueous solution has a characteristic bitter-savory taste similar to amino-acid solutions. Sports-nutrition liquid-shot manufacturers use flavoring systems (citrus, berry, sweetener combinations) to mask the bitterness at typical 1-3% LCLT dosing.
Dust Handling. Standard NFPA 654 / NFPA 652 housekeeping practices for fine-powder handling apply: prevent dust accumulation, bond and ground all metal handling equipment, intrinsically-safe dust-rated electrical fixtures in bag-tip / supersack-discharge zones. Bulk LCLT handling is not specifically high-hazard relative to other amino-acid powder handling.
Identity and Assay Acceptance Testing. Per USP and FDA cGMP, every received lot of pharmaceutical-grade L-carnitine API or infant-formula-grade LCLT must be identity-tested at receipt: IR spectroscopy plus a chemical confirmation. Optical-rotation testing distinguishes L-carnitine (-29.5 to -32.5° for free base) from D-carnitine (the stereoisomer, +rotation, which has no biological activity in mammals and is a key adulteration concern in low-cost dietary-supplement supply). HPLC quantitation per the monograph procedure follows. The Lonza Carnipure brand premium pricing reflects strict L:D enantiomer-purity certification (typically >99.5% L-form) which is a meaningful differentiator from low-cost Chinese-domestic supply where racemic contamination is a periodic quality concern.
Spill Response. Dry powder spills are vacuum-cleaned with HEPA-filtered industrial vacuum (NEVER swept dry). Aqueous solution spills are absorbed with universal absorbent material and disposed as non-hazardous waste. The chemistry is benign at occupational-exposure levels.
Tartrate Counter-Ion Recognition. Field-receiving inspection should verify the LCLT specification on the COA (certificate of analysis) matches the purchase-order specification. Substitution of L-carnitine fumarate (a different counter-ion salt form), DL-carnitine HCl (racemic with HCl counter-ion), or even L-carnitine HCl is a periodic supply-chain quality issue, particularly for low-cost Chinese-domestic-direct supply. Optical-rotation testing + HPLC counter-ion identification at receiving catches these substitutions.
Talk to OneSource Plastics
Listed price covers tank + standard fitting package; LTL freight is quoted separately to your delivery ZIP. Call 866-418-1777, use our freight estimator, or try our chemical tank recommender to narrow material selection.